Stay updated on Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial
Sign up to get notified when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.

Latest updates to the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedThe page displays a new Revision: v3.3.2 label, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check53 days agoChange DetectedRemoved the government funding/operating status notice from the page. The study details and eligibility criteria remain unchanged.SummaryDifference0.3%

- Check67 days agoChange DetectedMinor UI/layout updates observed on the Study Details page, with no changes to core study data, eligibility, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check96 days agoChange DetectedMajor update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.SummaryDifference4%

- Check103 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ledipasvir/Sofosbuvir 12-Week Combo in Genotype 2 HCV Clinical Trial page.